Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs Suncor Energy Inc. — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $220.35 (market cap $29.60B), while Suncor Energy Inc. trades at $63.3 (market cap $74.07B). The key difference: Suncor Energy Inc. is far larger — about 2.5× Alnylam Pharmaceuticals, Inc.'s market cap, and Suncor Energy Inc. pays a 2.7% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.
| ALNY | SU | |
|---|---|---|
Market Cap | $29.60B | $74.07B |
Sector | Health | Energy |
52-Week High | $491.22 | $69.73 |
52-Week Low | $205.48 | $38.17 |
Enterprise Value | $27.56B | $80.75B |
Dividend Yield | — | 2.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Suncor Energy (SU) trades at $62.73, up 4.38% today, with a bearish technical signal but strong fundamentals including a P/E of 11.79 and net margin of 14.7%. Recent Q2 2026 earnings beat estimates at $2.27 EPS, driven by higher crude realizations and refining margins (Reuters, 2026-08-04). The company maintains a consistent dividend of $0.60 per share and announced a CEO transition to Peter Zebedee in 2027.
Outlook is supported by solid cash flow and buybacks, but risks include commodity price volatility and operational disruptions. Analyst consensus is strongly bullish with 74% buy ratings, targeting upside from efficient operations and debt reduction, though technical weakness near support at $61 may limit near-term gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
